INNOVATE Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that INNOVATE Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.11B | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.42B | Mar 31, 2025 |
| FY2022 | Dec 31, 2022 | $1.64B | Mar 14, 2023 |
| FY2022 | Dec 31, 2021 | $1.21B | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $171.80M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $716.90M | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $393.30M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $377.00M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | $186.60M | May 7, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.42B | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | $1.64B | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $1.21B | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $171.80M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $716.90M | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $317.20M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $299.40M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | $186.60M | May 7, 2021 |
| FY2020 | Dec 31, 2019 | $755.60M | Mar 10, 2021 |
| FY2020 | Sep 30, 2019 | $349.30M | Nov 9, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $418.95M | Mar 14, 2018 |
| FY2017 | Sep 30, 2017 | $368.67M | Mar 14, 2018 |
| FY2017 | Jun 30, 2017 | $340.38M | Mar 14, 2018 |
| FY2017 | Mar 31, 2017 | $354.54M | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $411.39M | Mar 14, 2018 |
| FY2017 | Sep 30, 2016 | $378.54M | Mar 14, 2018 |
| FY2017 | Jun 30, 2016 | $323.13M | Mar 14, 2018 |
| FY2017 | Mar 31, 2016 | $302.61M | Mar 14, 2018 |
| FY2017 | Dec 31, 2015 | $1.12B | Mar 14, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $199.70M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $208.80M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $216.00M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $221.40M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $183.70M | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $30.50M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $128.40M | Mar 9, 2022 |
| FY2021 | Mar 31, 2020 | $29.80M | May 7, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($60.60M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($34.60M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($35.20M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($35.90M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | ($227.50M) | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $12.60M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | ($92.00M) | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | ($17.30M) | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $13.10M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | ($83.10M) | May 7, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.70M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $40.00M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $26.50M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $13.40M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | ($10.60M) | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | ($10.90M) | May 7, 2021 |
| FY2021 | Dec 31, 2020 | ($28.30M) | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | ($2.10M) | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $4.90M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | ($13.60M) | May 7, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $153.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $160.20M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $168.00M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $180.10M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $168.30M | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $37.10M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $145.50M | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $45.20M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $48.10M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | $38.90M | May 7, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $146.60M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $9.10M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $26.50M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($9.50M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $27.00M | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | ($2.50M) | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $41.10M | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $77.40M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $47.80M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | $35.30M | May 7, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $19.00M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $18.40M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $20.70M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $24.10M | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $3.20M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $17.80M | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $16.70M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $11.70M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | $5.00M | May 7, 2021 |
| FY2020 | Dec 31, 2019 | $24.70M | Mar 10, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $950.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $891.10M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.04B | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.15B | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $1.08B | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $6.41B | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $6.72B | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $6.69B | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $6.63B | Aug 10, 2020 |
| FY2020 | Mar 31, 2020 | $6.34B | May 11, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.03B | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.18B | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.18B | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $1.07B | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $5.97B | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $6.11B | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $6.25B | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $6.25B | Aug 10, 2020 |
| FY2020 | Mar 31, 2020 | $6.26B | May 11, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($240.10M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($180.40M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($165.50M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($121.30M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | ($84.30M) | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | $389.60M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | $559.80M | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | $371.80M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $319.30M | Aug 10, 2020 |
| FY2020 | Mar 31, 2020 | $14.10M | May 11, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.00M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $126.70M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $127.10M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $127.10M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $127.40M | Mar 6, 2024 |
| FY2021 | Mar 31, 2021 | $110.90M | May 7, 2021 |
| FY2022 | Dec 31, 2020 | $111.00M | Mar 14, 2023 |
| FY2020 | Sep 30, 2020 | $112.70M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $112.60M | Aug 10, 2020 |
| FY2020 | Mar 31, 2020 | $112.00M | May 11, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($582.50M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($521.90M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($487.30M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($452.10M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | ($416.20M) | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | ($176.10M) | May 7, 2021 |
| FY2021 | Dec 31, 2020 | ($188.70M) | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | ($184.00M) | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | ($166.70M) | Aug 10, 2020 |
| FY2020 | Mar 31, 2020 | ($179.80M) | May 11, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $48.80M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $80.80M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $80.40M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $45.50M | Mar 6, 2024 |
| FY2021 | Mar 31, 2021 | $54.20M | May 7, 2021 |
| FY2022 | Dec 31, 2020 | $43.80M | Mar 14, 2023 |
| FY2020 | Sep 30, 2020 | $163.60M | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | $203.80M | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | $14.90M | May 7, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $388.70M | Mar 9, 2017 |
| FY2015 | Dec 31, 2015 | $381.61M | Mar 15, 2016 |
| FY2014 | Dec 31, 2014 | $345.72M | Mar 15, 2016 |
| FY2012 | Dec 31, 2012 | $127.78M | Mar 14, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | (4) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | 0 | May 7, 2021 |
| FY2021 | Dec 31, 2020 | (1) | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | 0 | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | (1) | May 7, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | (4) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | 0 | May 7, 2021 |
| FY2021 | Dec 31, 2020 | (1) | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | 0 | Nov 9, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Aug 10, 2020 |
| FY2021 | Mar 31, 2020 | (1) | May 7, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.66M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 13.26M | Mar 26, 2026 |
| FY2025 | Aug 8, 2024 | 13.17M | Mar 26, 2026 |
| FY2025 | Aug 7, 2024 | 130.53M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 7.92M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 78.79M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | 77.84M | Mar 14, 2023 |
| FY2021 | Mar 31, 2021 | 77.56M | May 7, 2021 |
| FY2021 | Dec 31, 2020 | 76.73M | Mar 9, 2022 |
| FY2020 | Sep 30, 2020 | 47.30M | Nov 9, 2020 |